EPHX2 and neoplasm: In addition, sEH knockout or sEH inhibitors reduce the chronic inflammatory bowel disease [14] and its associated tumor formation [15] in IL-10 knockout mice, which was also associated with a reduction in TNFα, MCP-1 and neutrophil infiltration [14].